Aquestive Therapeutics

0 followers


Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117.

Employees

201-500

Links

Org chart

Daniel Barber
CEO, President & Director

Daniel Barber

Collapse
Mark Schobel
Chief Innovation & Technology Officer
Carl Kraus
Chief Medical Officer
Lori J. Braender
SVP, General Counsel
Cassie Jung
SVP, Operations
Stephen Wargacki
SVP, Research & Development
Amy Santos
Vice President, Global Quality Assurance
Patricia Lasquinha
Office Manager/executive Assistant Ceo/cito
Joseph Crusco
Director Business Development